Ocular Therapeutix
Price & Volume
Stats
See more52W Range | $6-$16.44 |
Market Cap | $1.5B |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $52M |
Revenue Growth (YoY) | 0.1% |
Gross Profit (12 Mos) | -$178.1M |
Diluted EPS | -$1.40 |
News
See moreYahoo Finance • 4 days ago
5 Best Biotech Stocks Under $10 to Buy
Yahoo Finance • 22 days ago
3 Healthcare Stocks We Find Risky
Yahoo Finance • 23 days ago
3 Unprofitable Stocks Walking a Fine Line
Yahoo Finance • 26 days ago
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Pravin U. Dugel M.D. |
Address | 14 Crosby Drive, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 325 |